Autotransfusion Systems (ATS) Market By Product and Service, By Application, By End User and Region: Global Industry Analysis, Share, Opportunity, Competition and Forecast 2022 to 2027

The Autotransfusion Systems (ATS) Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report. The market report additionally gives a to-the-point evaluation of the techniques and plans of action that are being executed by the players and companies to contribute to the Autotransfusion Systems (ATS) market growth.

The Global Autotransfusion Systems (ATS) Market Size is Projected to Reach at a CAGR of 5% during 2022-2027.

Click Here to Get a Free Sample Copy (Exclusive Offer: Flat 30% Discount for A Limited Time):

https://www.marketintelligencedata.com/reports/1349110/global-autotransfusion-systems-ats-market-growth-2022-2028/inquiry?Mode=Rukaiyya

Market Overview

 The major factor attributing to the growth of the market is the increase in the number of surgical procedures which can be attributed to the increase in the prevalence of chronic disease and increasing prevalence of lifestyle diseases, due to sedentary living. Furthermore, the scarcity of donated blood or allogeneic blood is also boosting the growth of the market. According to NPR.org in India, across all 107 countries with an insufficient supply of blood, the shortfall counted up to 100 million units of blood. Of those, 41 million were needed in India. However, the high cost of the auto-transfusion devices and the risk associated with the procedure constraints the market growth.

Top Leading Companies:

BD (Bard), LivaNova, Fresenius Kabi, Haemonetics, Medtronic

Recent Development:

LivaNova (UK) holds a strong position in the market. LivaNova offers its autotransfusion systems through its Cardiovascular segment. The company is recognized as a world leader in autotransfusion due to its experience and commitment to innovative solutions research. Since 2010, XTRA, LivaNova’s latest extraordinarily innovative, intuitive, and powerful ATS system, featuring innovative technological characteristics, ease of use, and powerful performance, has been supporting clinicians in meeting patient blood management goals. XTRA has helped over one million patients reduce allogeneic transfusion risks and shorten their hospital stays.
Haemonetics (US) has successfully positioned itself as a strong player in the market. The company has a strong portfolio in providing products for blood, plasma, and whole blood cells. The company’s Cell Saver Elite system provides hospitals with an easy-to-use, reliable way to recover and deliver back a patient’s own high-quality blood during medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular, and OBGYN surgeries. On the other hand, in the past three years, the company has not made any significant development in the autotransfusion systems market. This may hamper Haemonetics’ position in the coming years. The company generates around 50% of its revenue from the US market. This may result in increased exposure of the company to the risk of demand fluctuations in local markets. Haemonetics can also focus on emerging markets such as Asia and Latin America, which offer high growth opportunities.

Autotransfusion Systems (ATS) Market Segmentation by Type:

Continuous Autotransfusion Systems
Discontinuous Autotransfusion Systems

Autotransfusion Systems (ATS) Market Segmentation by Application:

Cardiac Surgery
Non-Cardiac Surgery

Explore Full Report with Detailed TOC Here:

https://www.marketintelligencedata.com/reports/1349110/global-autotransfusion-systems-ats-market-growth-2022-2028?Mode=Rukaiyya

We will get in touch with you within 24hrs and help you find the research reports and Additional Customization you need.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, a high number of surgeries the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and awareness of auto-transfusion due to lack of allogenic blood in the region are some of the drivers expected to increase the market growth. In this region, the United States has the maximum share due to supportive healthcare policies, and a developed healthcare market. According to the American National Red Cross, approximately 36,000 units of red blood cells are needed every day in the United States. As per the statistics, the increasing deficit of the donated blood and increasing disposable revenue in this country boosts the market growth of the region.

Regional Autotransfusion Systems (ATS) Market (Regional Output, Demand & Forecast by Countries)

North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Ecuador, Chile)
Asia Pacific (China, Japan, India, Korea)
Europe (Germany, UK, France, Italy)
Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) And additional.

Buy Full Report Here:

https://www.marketintelligencedata.com/report/purchase/1349110?mode=su?Mode=Rukaiyya

Highlights of the Autotransfusion Systems (ATS) Market Report:

Detailed overview of Autotransfusion Systems (ATS) Market
Changing the Autotransfusion Systems (ATS) market dynamics of the industry
In-depth market segmentation by Type, Application, etc.
Historical, current and projected Autotransfusion Systems (ATS) market size in terms of volume and value
Recent industry trends and developments
Competitive landscape of Autotransfusion Systems (ATS) Market
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth.

The research includes historic data from 2017 to 2022 and forecasts until 2026 which makes the report an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Finally, the Autotransfusion Systems (ATS) Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. Autotransfusion Systems (ATS) industry report additionally Presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.

We Offer Customization on Report Based on Specific Client Requirement:

– Country Level analysis for any 5 countries of your choice.

– Competitive analysis of any 5 key market players.

– 40 analyst hours to cover any other data point.

– 15% customization equal to 60 analyst hours.

ABOUT US:

Market intelligence data is a global front-runner in the research industry, offering customers contextual and data-driven research services. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact Us:

Irfan Tamboli (Head of Sales) – MARKET INTELLIGENCE DATA

Phone: +1 (704) 266-3234

Mail to: sales@marketintelligencedata.com

This release was published on openPR.